| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gastrointestinal Imaging |
2-cm) Early-Enhancing Hepatic Lesions with Serial Contrast-enhanced Dynamic MR Imaging1
1 From the Department of Radiology, Yamaguchi University School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505 Japan. Received December 3, 2001; revision requested February 14, 2002; revision received April 5; accepted June 24. Address correspondence to A.S. (e-mail: ayamechan51@hotmail.com).
PURPOSE: To evaluate the frequency and clinical importance of small (
2 cm) early-enhancing hepatic lesions in cirrhotic liver disease with serial multiphasic contrast material–enhanced dynamic magnetic resonance (MR) imaging.
MATERIALS AND METHODS: The study population included 208 patients with cirrhosis (n = 162) or chronic hepatitis (n = 46) who underwent dynamic contrast-enhanced MR imaging at least twice during the clinical course, with at least a 12-month interval between the initial and latest MR examinations. Initial images were evaluated for the presence and shape of small (2 cm) early-enhancing hepatic lesions at arterial-phase contrast-enhanced MR imaging. If a small early- enhancing lesion was seen on the initial image, the latest follow-up image was reviewed to assess the serial changes in the features of a specific lesion.
RESULTS: One hundred fifty-eight small early-enhancing lesions were detected in 75 (36%) of the 208 patients on the initial MR images. Of those 158 lesions, 104 were round or oval, 30 wedge-shaped, 18 geographic (irregularly shaped), and six triangular. Among the 104 round or oval lesions, 54 (52%) disappeared or decreased in size on the latest MR images and were considered definite pseudolesions. Twenty-nine (28%) of the 104 round or oval lesions were classified as hepatocellular carcinoma (HCC) on the basis of their interval growth or pathologic confirmation. The remaining 21 (20%) lesions were stable in size and appearance and considered probable pseudolesions. For the other three shapes, 73% of wedge-shaped, 78% of geographic, and 67% of triangular lesions disappeared or decreased in size.
CONCLUSION: Small early-enhancing hepatic lesions in patients with cirrhosis usually showed no interval growth or disappeared during serial contrast-enhanced dynamic MR imaging. Even though these lesions are round or oval, they may more frequently be pseudolesions than HCCs.
© RSNA, 2003
Index terms: Hepatitis, 761.291 • Liver, cirrhosis, 761.794 • Liver, MR, 761.121411, 761.121412 • Liver neoplasms, MR, 761.323 • Magnetic resonance (MR), contrast media • Shunts, arterioportal
This article has been cited by other articles:
|
|
 |
|
  C. Verslype, E. Van Cutsem, M. Dicato, N. Arber, J. D. Berlin, D. Cunningham, A. De Gramont, E. Diaz-Rubio, M. Ducreux, T. Gruenberger, et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008 Ann. Onc., June 1, 2009; 20(suppl_7): vii1 - vii6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Marin, M. Di Martino, A. Guerrisi, G. De Filippis, M. Rossi, S. Ginanni Corradini, R. Masciangelo, C. Catalano, and R. Passariello Hepatocellular Carcinoma in Patients with Cirrhosis: Qualitative Comparison of Gadobenate Dimeglumine-enhanced MR Imaging and Multiphasic 64-Section CT Radiology, April 1, 2009; 251(1): 85 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goshima, M. Kanematsu, H. Kondo, Y. Shiratori, M. Onozuka, N. Moriyama, and K. T. Bae Optimal Acquisition Delay for Dynamic Contrast-Enhanced MRI of Hypervascular Hepatocellular Carcinoma Am. J. Roentgenol., March 1, 2009; 192(3): 686 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Marin, C. Catalano, G. De Filippis, M. Di Martino, A. Guerrisi, M. Rossi, and R. Passariello Detection of Hepatocellular Carcinoma in Patients with Cirrhosis: Added Value of Coronal Reformations from Isotropic Voxels with 64-MDCT Am. J. Roentgenol., January 1, 2009; 192(1): 180 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies Radiology, May 1, 2008; 247(2): 311 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ronzoni, D. Artioli, R. Scardina, L. Battistig, E. Minola, S. Sironi, and A. Vanzulli Role of MDCT in the Diagnosis of Hepatocellular Carcinoma in Patients with Cirrhosis Undergoing Orthotopic Liver Transplantation Am. J. Roentgenol., October 1, 2007; 189(4): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Choi, D. G. Mitchell, S. K. Verma, D. Bergin, V. J. Navarro, A. B. Malliah, C. McGowan, H.-W. L. Hann, and S. K. Herrine Hepatocellular Carcinoma with Indeterminate or False-Negative Findings at Initial MR Imaging: Effect on Eligibility for Curative Treatment Initial Observations Radiology, September 1, 2007; 244(3): 776 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kanematsu, S. Goshima, H. Kondo, Y. Tsuge, R. Yokoyama, K. Kajita, M. Onozuka, Y. Suzuki, M. Van Cauteren, and N. Moriyama Gadolinium-Enhanced Multiphasic 3D MRI of the Liver with Prospective Adaptive Navigator Correction: Phantom Study and Preliminary Clinical Evaluation Am. J. Roentgenol., April 1, 2007; 188(4): W309 - W316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kanematsu, S. Goshima, H. K. Hussain, T. D. Johnson, H. V. Nghiem, and I. R. Francis Does T2-weighted MR Imaging Really Add No Value in Detection and Characterization of Focal Lesions in Cirrhotic Liver? * Dr Hussain and colleagues respond: Radiology, February 1, 2005; 234(2): 638 - 640. [Full Text]
|
|
|
|
|
|
K. Ito, T. Fujita, A. Shimizu, S. Koike, K. Sasaki, N. Matsunaga, S. Hibino, and M. Yuhara Multiarterial Phase Dynamic MRI of Small Early Enhancing Hepatic Lesions in Cirrhosis or Chronic Hepatitis: Differentiating Between Hypervascular Hepatocellular Carcinomas and Pseudolesions Am. J. Roentgenol., September 1, 2004; 183(3): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
